Analyst Price Target is $84.50
▲ +18.02% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Bruker in the last 3 months. The average price target is $84.50, with a high forecast of $98.00 and a low forecast of $70.00. The average price target represents a 18.02% upside from the last price of $71.60.
Current Consensus is
The current consensus among 3 investment analysts is to hold stock in Bruker. This rating has held steady since January 2023, when it changed from a Buy consensus rating.
Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) BioSpin, BSI Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID), BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The BSI CALID segment includes the design and distribution of life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions based on infrared and Raman molecular spectroscopy technologies and radiological/nuclear detectors for Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) detection. The BSI Nano segment offers x-ray instruments that use electromagnetic radiation with wavelengths to determine the characteristics of matter and the three-dimensional (3D) structure of molecules. The BEST segment consist